Tulane awarded $8.7 million to work with Black churches to eliminate cardiovascular health disparities
November 16, 2020
The National Institutes of Health awarded a $8.7 million grant to Tulane University to study whether churches can play a significant role in helping to eliminate cardiovascular health disparities among African Americans.
Tulane begins recruiting for Janssen COVID-19 vaccine study
November 03, 2020
Tulane University School of Medicine will be a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III clinical research study of a new COVID-19 vaccine.
Tulane researcher awarded grant for study on weed invasion
October 19, 2020
A Tulane researcher will use a grant from the U.S. Department of Agriculture to study the impact of noxious weed invasion on livestock, food production and supermarket prices.
Tulane awarded $2.5 million to study if removing copayments improves diabetes outcomes
October 16, 2020
The U.S. Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2.5 million grant to Tulane University School of Public Health and Tropical Medicine to work with community partners determine if a value-based benefit approach using zero-cost copayments on drugs can improve medication adherence and outcomes for diabetes patients.
Tulane report shows inequities in New Orleans startup activity and access to funding
October 12, 2020
Tulane University’s A. B. Freeman School of Business released the second edition of the Greater New Orleans Startup Report, an annual comprehensive overview of the region’s entrepreneurial ecosystem.
Neurology chair dedicated to dementia prevention and brain health
October 07, 2020
Demetrius “Demetri” Maraganore, MD, is the recently appointed Herbert J. Harvey, Jr. Chair in Neurosciences and Chair of the Department of Neurology at Tulane University School of Medicine, where he runs the Healthy Brain Aging Initiative that helps patients prevent cognitive decline and dementia, including Alzheimer’s disease.
Tulane University scientist awarded $1.2 million grant geared to talented and promising investigators
October 05, 2020
Tulane researcher Kathleen Ferris will use a $1.2 million NIH grant to study the genetics and evolution of ecologically important traits in monkeyflowers, a wildflower native to western North America.
Tulane graduates selected for National Science Foundation Innovation Corps program
October 02, 2020
Alexander B. Simon and Alexander D. Wise, both recent graduates from Tulane’s chemical and biomolecular engineering program, participated in the National Science Foundation Innovation Corps, or NSF I-Corps, program this past summer.
What we know about COVID-19 immunity
September 25, 2020
Almost seven months into the global COVID-19 pandemic, scientists are still working to answer key questions about how the body develops immunity — and whether it's lasting.
New podcast focuses on COVID immunity
September 18, 2020
The “On Good Authority” podcast presents Tulane experts discussing leading issues in the news.
Clinical trial to test effectiveness of drug in treating cancer patients with severe COVID-19
September 11, 2020
Nakhle Saba, MD, associate professor of clinical medicine, is principal investigator on a trial to treat severe COVID-19 in hospitalized cancer patients.
Tulane researcher awarded $3 million to address aging and disease impacts on the brain
September 03, 2020
New research projects underway at Tulane University School of Medicine aim to understand why aging and conditions such as type 2 diabetes impact the brain.
Tulane researcher recognized for work in artificial intelligence
August 31, 2020
Tulane researcher Nicholas Mattei is being recognized twice for his work in artificial intelligence.
Tulane researchers awarded Fast Grant for second-generation COVID-19 vaccine
August 27, 2020
Two Tulane University researchers were awarded a $150,000 Fast Grant for a project to make next-generation COVID-19 vaccines more effective.
Metabolic syndrome linked to worse outcomes for COVID-19 patients
August 25, 2020
Patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity and diabetes were over three times more likely to die from the disease, according to a new Tulane University study.